Market revenue in 2023 | USD 1,525.7 million |
Market revenue in 2030 | USD 1,873.9 million |
Growth rate | 3% (CAGR from 2023 to 2030) |
Largest segment | Static compression therapy |
Fastest growing segment | Dynamic Compression Therapy |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Static Compression Therapy, Dynamic Compression Therapy |
Key market players worldwide | Cardinal Health Inc, Hartmann Holdings, Svenska Cellulosa AB ADR, ArjoHuntleigh, 3M Co, Spectrum Healthcare Resources, Bio Compression Systems, Stryker Corp, Ohio Valley Banc Corporation, Tactile Medical, Essity, Juzo, Harbor Health Care ETF, Sigvaris |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to compression therapy market will help companies and investors design strategic landscapes.
Static compression therapy was the largest segment with a revenue share of 66.19% in 2023. Horizon Databook has segmented the U.S. compression therapy market based on static compression therapy, dynamic compression therapy covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. population's aging demographic is leading to an increased prevalence of conditions such as Peripheral Artery Disease (PAD), a common indication for compression therapy. According to a research article published by Vascular Disease Management in April 2023, the U.S. population's PAD prevalence has increased from 11.3 million in 1995 to an estimated 26 million in 2020.
This increase can be attributed to an aging population, and the number is projected to reach 23.8 million by 2030 due to the aging population. Furthermore, growing awareness about the benefits of compression therapy in managing various conditions, including PAD, Deep Vein Thrombosis (DVT), and post-thrombotic syndrome, is driven by research, clinical trials, and patient testimonials.
Moreover, policies such as the Medicare Access and CHIP Reauthorization Act (MACRA) have encouraged the use of compression therapy by providing incentives for its use in managing PAD.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. compression therapy market, including forecasts for subscribers. This country databook contains high-level insights into U.S. compression therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account